quinupristin/dalfopristin will enhance the stage or result of avanafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. CYP3A4 inhibitors could decrease avanafil clearance increasing systemic publicity to avanafil; greater degrees may perhaps bring about greater associate